Search

Your search keyword '"Catucci, Angelo Emanuele"' showing total 5 results
Start Over Author "Catucci, Angelo Emanuele"
5 results on '"Catucci, Angelo Emanuele"'

1. Waves of infection and waves of communication: the importance of sharing in the era of Covid-19

Author

Mazzaferro, Sandro, Rocca, Anna Rachele, Bagordo, Domenico, Alfarone, Carmelo, Baldinelli, Guido, Boccia, Eligio, Bondatti, Franco, Casarci, Marta, Catucci, Angelo Emanuele, Chiappini, Maria Grazia, Cioffi, Anselmo, Cuzziol, Carlo, De Paolis, Paolo, Della Grotta, Barbara, Daniele, Nicola Di, Di Lullo, Luca, Di Pietro, Gabriele, Di Zazzo, Giacomo, Fazzari, Loredana, Feriozzi, Sandro, Ferrazzano, Mariateresa, Filippini, Armando, Fini, Riziero, Firmi, Gabriele, Flammini, Alessandro, Forte, Franco, Galliani, Marco, Gamberini, Marco, Gangeri, Fabio, Grandaliano, Giuseppe, Iamundo, Vanda, Lavini, Raffaella, Lonzi, Maurizio, Marinelli, Rocco, Marrocco, Fulvio, Menè, Paolo, Miglio, Lucio, Morabito, Santo, Morgia, Augusto, Morosetti, Massimo, Muci, Maria Luisa, Nazzaro, Livia, Nusca, Carlo, Onorato, Leandro, Pace, Gabriella, Palumbo, Roberto, Pantano, Lucia, Polito, Pasquale, Puliti, Marialaura, Rifici, Nunzio, Rizzi, Elsa, Rossi, Valeria, Sabry, Hassan, Scabbia, Luca, Serraiocco, Monica, Sfregola, Pietro, Simonelli, Roberto, Treglia, Antonio, Umbro, Ilaria, and Valentini, Walter

Subjects
2019-20 coronavirus outbreak, Coronavirus disease 2019 (COVID-19), COVID19, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), MEDLINE, Ambulatory Care Facilities, Renal Dialysis, Surveys and Questionnaires, Prevalence, Humans, Settore MED/14 - NEFROLOGIA, Medicine, Cooperative Behavior, Information Dissemination, SARS-CoV-2, business.industry, COVID-19, Italy, Occupational Diseases, Peritoneal Dialysis, medicine.disease, Editorial, Nephrology, Hemodialysis, Medical emergency, business
Published
2021

5. Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.

Author

Vianelli N, Palandri F, Polverelli N, Stasi R, Joelsson J, Johansson E, Ruggeri M, Zaja F, Cantoni S, Catucci AE, Candoni A, Morra E, Björkholm M, Baccarani M, and Rodeghiero F

Subjects
Adolescent, Adult, Aged, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Incidence, Infant, Male, Middle Aged, Postoperative Complications epidemiology, Prognosis, Purpura, Thrombocytopenic, Idiopathic drug therapy, Purpura, Thrombocytopenic, Idiopathic mortality, Retrospective Studies, Treatment Outcome, Young Adult, Purpura, Thrombocytopenic, Idiopathic surgery, Splenectomy
Abstract

The treatment of choice in steroid-resistant immune thrombocytopenia is still controversial due to the recent advent of new drugs (anti-CD20 antibodies and thrombopoietin mimetics) that have encouraged a generalized tendency to delay splenectomy. Consequently, it is extremely importance to define the efficacy and safety of splenectomy in the long term. We retrospectively analyzed the data of 233 patients affected by immune thrombocytopenia who underwent splenectomy between 1959 and 2001 in 6 European hematologic institutions and who have now a minimum follow up of ten years from surgery. Of the 233 patients, 180 (77%) achieved a complete response and 26 (11%) a response. Sixty-eight of 206 (33%) responsive patients relapsed, mostly (75%) within four years from first response. In 92 patients (39.5%), further treatment was required after splenectomy that was effective in 76 cases (83%). In 138 patients (59%), response was maintained free of any treatment at last contact. No significant association between baseline characteristics and likelihood of stable response was found. Overall, 73 (31%) and 58 (25%) patients experienced at least one infectious or hemorrhagic complication, which was fatal in 2 and 3 patients, respectively. A stable response to splenectomy was associated with a lower rate of infections (P=0.004) and hemorrhages (P<0.0001). Thrombosis developed in 18 patients (8%) and was fatal in 4. Splenectomy achieved a long-term stable response in approximately 60% of cases. Complications mainly affected non-responding patients and were fatal in a minority.

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results